Last reviewed · How we verify
Prevention of Development of Transcutaneous Sensitization in Children With Atopic Dermatitis During Their First Year of Life
This experimental non-randomized clinical study is aimed at comparing the efficacy and safety assessment of the proposed topical therapy algorithms with the use of topical calcineurin inhibitors in reducing the severity of atopic dermatitis and the degree of development of transcutaneous sensitization in children of the first year of life.
Details
| Lead sponsor | National Medical Research Center for Children's Health, Russian Federation |
|---|---|
| Phase | PHASE4 |
| Status | COMPLETED |
| Enrolment | 108 |
| Start date | Sun Dec 10 2017 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Sat Apr 25 2020 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Atopic Dermatitis
Interventions
- Pimecrolimus cream 1%
- cream 0.1% methylprednisolone aceponate
Countries
Russia